The Science

At Reveal, we strive to revolutionize healthcare by providing hormone optimization and precision and preventative medicine. Our approach is firmly grounded in our commitment to scientific and clinical research, which is why we maintain an ever-expanding collection of peer-reviewed white papers and studies to share our developments with the world.

We believe that compounded bio-identical hormone pellet therapy, which was originally created in 1939 for women who underwent radical hysterectomies, has the potential to be a game-changer in hormone replacement therapy. This form of therapy has been widely used in Europe and Australia and is the longest studied form of hormone replacement therapy to date. However, to build confidence within the scientific community and provide patients with access to a broader continuum of options, further study is required.

At Reveal, we are committed to being at the forefront of the hormone optimization industry by advocating for quality and accessibility of information. Human hormones are unique to each individual, so personalized compounded solutions are needed to provide patients with greater flexibility and accessibility than other forms of hormone therapy can offer. We are calling for more clinical research in the often misconstrued and underutilized field of hormone therapy. In just over a decade, we have gained valuable insights from over 2.5 million pellet insertions, which we are eager to share with the world.

We recognize that there is a significant gap in formal clinical research and education when it comes to hormone therapy. That’s why we gather experiential insights to help guide the direction of clinical research and confirm the real-world data that patients experience with scientific evidence. By doing so, we aim to become a leading industry voice for hormone optimization and work towards providing patients with safe and effective treatments. If you have any questions or concerns about hormone therapy, feel free to ask us. We’re here to help.